Страна: Австралия
Язык: английский
Источник: Department of Health (Therapeutic Goods Administration)
nicotine polacrilex, Quantity: 13.33 mg (Equivalent: nicotine, Qty 2 mg)
Orion Laboratories Pty Ltd T/A Perrigo Australia
Nicotine polacrilex
Tablet, uncoated
Excipient Ingredients: mannitol; sodium carbonate; xanthan gum; potassium bicarbonate; sodium alginate; magnesium stearate; aspartame; Flavour
Buccal
120, 108, 96, 156, 36, 144, 132, 168, 72
Not Scheduled after consideration by Committee
Relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. Nicotine Lozenges may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. If possible, when stopping smoking, should be used in conjunction with behavioural support program.
Visual Identification: Cream/white embossed biconvex round tablet with an odour of peppermint. Embossed with 'L344' on one face.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2013-08-15